AspenBio Pharma, Inc. 4/A
4/A · AspenBio Pharma, Inc. · Filed Jul 14, 2006
Insider Transaction Report
Form 4/AAmended
Donnelly Richard G
DirectorPresident & CEO
Transactions
- Other
Options (Right to Buy)
2006-07-01−100,000→ 0 totalExercise: $0.96From: 2006-07-01Exp: 2015-12-23→ Common Stock (100,000 underlying) - Purchase
Common Stock
2006-07-13$1.45/sh+10,000$14,500→ 221,537 total
Holdings
- 28,571
Warrants (Right to Buy)
Exercise: $1.35From: 2005-05-06Exp: 2010-05-06→ Common Stock (28,571 underlying) - 500,000
Options (Right to Buy)
Exercise: $0.60From: 2005-02-01Exp: 2015-02-01→ Common Stock (500,000 underlying)
Footnotes (3)
- [F1]Options vest over three years, at the rate of 33.3% at the end of year one, 66.7% at the end of year two, and 100% at the end of year three.
- [F2]Units purchased at a unit price of $0.875, with each unit consisting of one warrant and one share of common stock.
- [F3]Options were cancelled on July 1, 2006 because the sales threshold required for vesting was not achieved by June 30, 2006. The cancellation of the options is exempt from Section 16(a) and 16(b) pursuant to Rule 16a-4(d) and Rule 16b-6(d), respectively.